Effect of the Accountable Care Act of 2010 on clinical trial insurance coverage

Sheetal Mehta Kircher, Al B Benson III*, Matthew Farber, Halla S Nimeiri

*Corresponding author for this work

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Purpose: The Affordable Care Act (ACA) of 2010 implemented dramatic changes in our health care system. The new law requires that insurers and health plans provide coverage for individuals participating in clinical trials. Currently, there are states that already have laws or agreements requiring clinical trial coverage, but there remain deficiencies that will need to be addressed to achieve compliance with the new law. Methods: State mandates were reviewed to determine current laws and agreements. The ACA was reviewed to outline its provisions, and these were compared with current mandates to identify deficiencies. Results: Eighteen states meet the requirements set forth by the ACA either through a state law or agreement; 33 states do not meet the requirements. Of these 33 states, 15 do not have any existing laws or agreements in place regarding clinical trials. In states that have deficient policies in place, the most common deficiency is the lack of phase I coverage. The second most common deficiency in policy is coverage of only therapeutic studies. Conclusion: Most states currently do not meet the requirements of the ACA and will be required to make changes by 2014. The implications of the ACA with regard to insurance coverage of clinical trials remain unclear as implementation of the legislation unfolds. State governments can take steps to ensure insurance coverage by creating and expanding agreements with insurance companies.

Original languageEnglish (US)
Pages (from-to)548-553
Number of pages6
JournalJournal of Clinical Oncology
Volume30
Issue number5
DOIs
StatePublished - Feb 10 2012

Fingerprint

Patient Protection and Affordable Care Act
Insurance Coverage
Clinical Trials
State Government
Insurance Carriers
Insurance
Legislation
Delivery of Health Care
Health

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{594ebf2f68f94b21a90b515b9172eee3,
title = "Effect of the Accountable Care Act of 2010 on clinical trial insurance coverage",
abstract = "Purpose: The Affordable Care Act (ACA) of 2010 implemented dramatic changes in our health care system. The new law requires that insurers and health plans provide coverage for individuals participating in clinical trials. Currently, there are states that already have laws or agreements requiring clinical trial coverage, but there remain deficiencies that will need to be addressed to achieve compliance with the new law. Methods: State mandates were reviewed to determine current laws and agreements. The ACA was reviewed to outline its provisions, and these were compared with current mandates to identify deficiencies. Results: Eighteen states meet the requirements set forth by the ACA either through a state law or agreement; 33 states do not meet the requirements. Of these 33 states, 15 do not have any existing laws or agreements in place regarding clinical trials. In states that have deficient policies in place, the most common deficiency is the lack of phase I coverage. The second most common deficiency in policy is coverage of only therapeutic studies. Conclusion: Most states currently do not meet the requirements of the ACA and will be required to make changes by 2014. The implications of the ACA with regard to insurance coverage of clinical trials remain unclear as implementation of the legislation unfolds. State governments can take steps to ensure insurance coverage by creating and expanding agreements with insurance companies.",
author = "Kircher, {Sheetal Mehta} and {Benson III}, {Al B} and Matthew Farber and Nimeiri, {Halla S}",
year = "2012",
month = "2",
day = "10",
doi = "10.1200/JCO.2011.37.8190",
language = "English (US)",
volume = "30",
pages = "548--553",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "5",

}

Effect of the Accountable Care Act of 2010 on clinical trial insurance coverage. / Kircher, Sheetal Mehta; Benson III, Al B; Farber, Matthew; Nimeiri, Halla S.

In: Journal of Clinical Oncology, Vol. 30, No. 5, 10.02.2012, p. 548-553.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Effect of the Accountable Care Act of 2010 on clinical trial insurance coverage

AU - Kircher, Sheetal Mehta

AU - Benson III, Al B

AU - Farber, Matthew

AU - Nimeiri, Halla S

PY - 2012/2/10

Y1 - 2012/2/10

N2 - Purpose: The Affordable Care Act (ACA) of 2010 implemented dramatic changes in our health care system. The new law requires that insurers and health plans provide coverage for individuals participating in clinical trials. Currently, there are states that already have laws or agreements requiring clinical trial coverage, but there remain deficiencies that will need to be addressed to achieve compliance with the new law. Methods: State mandates were reviewed to determine current laws and agreements. The ACA was reviewed to outline its provisions, and these were compared with current mandates to identify deficiencies. Results: Eighteen states meet the requirements set forth by the ACA either through a state law or agreement; 33 states do not meet the requirements. Of these 33 states, 15 do not have any existing laws or agreements in place regarding clinical trials. In states that have deficient policies in place, the most common deficiency is the lack of phase I coverage. The second most common deficiency in policy is coverage of only therapeutic studies. Conclusion: Most states currently do not meet the requirements of the ACA and will be required to make changes by 2014. The implications of the ACA with regard to insurance coverage of clinical trials remain unclear as implementation of the legislation unfolds. State governments can take steps to ensure insurance coverage by creating and expanding agreements with insurance companies.

AB - Purpose: The Affordable Care Act (ACA) of 2010 implemented dramatic changes in our health care system. The new law requires that insurers and health plans provide coverage for individuals participating in clinical trials. Currently, there are states that already have laws or agreements requiring clinical trial coverage, but there remain deficiencies that will need to be addressed to achieve compliance with the new law. Methods: State mandates were reviewed to determine current laws and agreements. The ACA was reviewed to outline its provisions, and these were compared with current mandates to identify deficiencies. Results: Eighteen states meet the requirements set forth by the ACA either through a state law or agreement; 33 states do not meet the requirements. Of these 33 states, 15 do not have any existing laws or agreements in place regarding clinical trials. In states that have deficient policies in place, the most common deficiency is the lack of phase I coverage. The second most common deficiency in policy is coverage of only therapeutic studies. Conclusion: Most states currently do not meet the requirements of the ACA and will be required to make changes by 2014. The implications of the ACA with regard to insurance coverage of clinical trials remain unclear as implementation of the legislation unfolds. State governments can take steps to ensure insurance coverage by creating and expanding agreements with insurance companies.

UR - http://www.scopus.com/inward/record.url?scp=84856878517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856878517&partnerID=8YFLogxK

U2 - 10.1200/JCO.2011.37.8190

DO - 10.1200/JCO.2011.37.8190

M3 - Review article

VL - 30

SP - 548

EP - 553

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 5

ER -